Results 191 to 200 of about 132,395 (346)
Abstract Purpose The demand for specialised eye care has quadrupled over the last two decades, driven by an aging population and the advent of new treatments. This surge has led to increased outsourcing by the Helsinki and Uusimaa Hospital District (HUS) Eye Hospital, initially relying on a fee‐for‐service model. This model, however, has been marked by
Susanna Moisander +7 more
wiley +1 more source
Allergic Contact Dermatitis to Povidone‐Iodine and Systemic Contact Dermatitis to Chloramphenicol, Used During Intravitreal Injection of Bevacizumab, an Anti‐Vascular Endothelial Growth Factor [PDF]
Tommaso Galeotti +4 more
openalex +1 more source
2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
A. Grzybowski +6 more
semanticscholar +1 more source
Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban +5 more
wiley +1 more source
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema [PDF]
Dilsher S. Dhoot +7 more
openalex +1 more source
A 66‐year‐old man with acute retinal necrosis
Brain Pathology, Volume 36, Issue 2, March 2026.
Shino Magaki +3 more
wiley +1 more source
Abstract Purpose Retinopathy of prematurity (ROP) is a major cause of childhood blindness, and selecting the optimal treatment between anti‐vascular endothelial growth factor (anti‐VEGF) and laser therapy is crucial. Understanding their impact on key outcomes, particularly mortality, is essential for informed clinical decision‐making.
Wei‐De Wang +10 more
wiley +1 more source
Continuity of care and risk of vision loss in patients with newly developed macular degeneration
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho +5 more
wiley +1 more source
Intravitreal anti-VEGF agents – The way forward
Sabyasachi Sengupta, Vishal Raval
openalex +1 more source

